Rethinking Clinical Trials

JULY 23, 2024

In an invited commentary published this month in Circulation: Cardiovascular Quality and Outcomes , authors from the NIH Pragmatic Trials Collaboratory’s Ethics and Regulatory Core describe the recurring and emerging ethical issues in pragmatic clinical trials. Coauthors Caleigh Propes, Stephanie Morain, and Pearl O’Rourke discuss 3 key challenges facing pragmatic trials researchers: waivers and alterations of informed consent and their implications for transparency managing and resp

Trials 317

Trials Clinical Trials Clinical Trials Doctors 317

Pharmaceutical Technology

JULY 23, 2024

Johnson & Johnson is seeking approval for SPRAVATO for treatment-resistant depression with the submission of an sNDA to the US FDA.

254

254

Bio Pharma Dive

JULY 22, 2024

The company plans to start a late-stage study next year, after a smaller trial found its drug offered “robust and consistent” benefits on communication, cognition and motor function.

Drugs 288

Drugs Trials 288

Pharmaceutical Technology

JULY 23, 2024

The latest resubmission addressed remaining CMC concerns, with the FDA confirming that the Phase III data was “sufficient”.

Gene Therapy 162

Gene Therapy Gene 162

Advertisement

Clinical Supply

Rethinking Clinical Trials

JULY 24, 2024

In this Friday’s PCT Grand Rounds, Gregg Fonarow of the University of California, Los Angeles, will present “Interventions for Optimization of Guideline-Directed Medical Therapy.” The Grand Rounds session will be held on Friday, July 26, 2024, at 1:00 pm eastern. Fonarow is the Eliot Corday Professor of Cardiovascular Medicine and Science at UCLA, director of the Ahmanson-UCLA Cardiomyopathy Center, and codirector of the UCLA Preventative Cardiology Program.

Cardiology 162

Cardiology Clinical Trials Clinical Trials Medicine 162

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 25, 2024

The search for alcohol hangover cures is as old as alcohol itself. Many cures and remedies are sold, but scientific evidence for their effectiveness is lacking. Recently, the notion that taking a shot of olive oil before consuming alcohol can prevent hangovers has garnered attention.

Clinical Trials 201

Clinical Trials Clinical Trials Clinical Research Trials 201

Pharmaceutical Technology

JULY 22, 2024

As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.

Marketing 344

Marketing 344

Worldwide Clinical Trials

JULY 26, 2024

At Worldwide Clinical Trials’ bioanalytical lab, we view challenges as opportunities to excel and set new standards. The path to drug approval is complex, with many variables and potential delays. That’s why our team is committed to continuous improvement through our initiative, WorldwideEdge, where we optimize everything from our processes to our teams’ performance for each drug development program.

Clinical Trials 182

Clinical Trials Clinical Trials Trials Development 182

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 23, 2024

Ultra long, thick eyelashes might be in vogue but are they worth the expense – and the risk to health? Our natural eyelashes perform important functions. The eye is exposed to the elements so it’s a window for bacteria and viruses to enter the body – potentially causing death.

Bacteria 205

Bacteria Clinical Trials Clinical Trials Trials 205

Bio Pharma Dive

JULY 22, 2024

Private biotech company acquisitions are on their fastest pace in years, a trend some in the industry say is driven by the abundance of mature, but not yet public, drug startups.

Marketing 249

Marketing Drugs 249

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Technology

JULY 22, 2024

As VP Kamala Harris enters the presidential race, her strong stances for reproductive rights and drug access offer insights into future actions.

Drugs 246

Drugs 246

Fierce Pharma

JULY 22, 2024

As lawmakers and industry groups seek to get a handle on U.S. | As lawmakers and industry groups seek to get a handle on U.S. drug shortages, a new white paper from German market analytics firm QYOBO supports the thesis that disproportionately low prices for generic medicines can make it difficult for drugmakers to keep supplies afloat.

Medicine 121

Medicine Marketing Drugs 121

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 24, 2024

We’ve known for over a century that mice and rats live longer when they are fed less, but a new study reveals the secret might be an imbalance between energy consumed and burned, rather than a lack of energy or protein.

Protein 196

Protein Research Clinical Trials Clinical Trials 196

Bio Pharma Dive

JULY 24, 2024

Autobahn’s lead candidate is designed to stimulate thyroid hormone receptors as a way to complement existing antidepressants.

Hormones 273

Hormones Drugs 273

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Pharmaceutical Technology

JULY 22, 2024

As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.

Marketing 245

Marketing 245

Fierce Pharma

JULY 25, 2024

Three months after bagging FDA approval, Pfizer’s hemophilia B gene therapy has been cleared to expand its reach across the pond. | The company's first gene therapy will debut in Europe as Durveqtix. In the U.S., the drug is approved under the brand name Beqvez.

Gene Therapy 116

Gene Therapy Gene FDA Approval Branding 116

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 25, 2024

Ahead of the upcoming Union Budget, prominent voices in the healthcare sector are urging the government to allocate substantial funds to support early diagnosis and intervention for children with autism and neurodevelopmental delays, alongside enhanced training for medical personnel on early disease detection.

Clinical Trials 191

Clinical Trials Clinical Trials Clinical Research Trials 191

Bio Pharma Dive

JULY 22, 2024

Serum-based glycoproteins demonstrate success in predicting immune checkpoint inhibitor therapy outcomes.

273

273

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Pharmaceutical Technology

JULY 24, 2024

The crowd and panel gave Gilead a standing ovation after the full data from the Phase III PURPOSE trial was announced at AIDS 2024.

Trials 246

Trials 246

Pharma Times

JULY 24, 2024

The neurodegenerative disease is currently the most common cause of dementia

Production 165

Production Research 165

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 22, 2024

Scientists have figured out a non-invasive way to determine if a transplanted organ is failing to take in a patient – no matter if it’s a kidney, liver, lung, or heart.

Scientist 153

Scientist Clinical Trials Clinical Trials Clinical Research 153

Bio Pharma Dive

JULY 26, 2024

Eisai plans to appeal the EMA’s negative recommendation, hoping to break into a market analysts expect could eventually bring billions of dollars in sales for the Alzheimer’s drug.

Regulation 171

Regulation Sales Marketing Drugs 171

Advertisement

Clinical Supply

Pharmaceutical Technology

JULY 25, 2024

JNJ-2056 is being investigated in the Phase IIb ReTain study which enrols participants who are yet to show Alzheimer’s symptoms.

Vaccination 246

Vaccination Vaccine 246

pharmaphorum

JULY 24, 2024

Stay updated on Matteo Levisetti, the chief medical officer at CUE Biopharma, post ASCO 2024. Learn about his latest research and contributions in the field of biopharma.

Research 116

Research 116

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 24, 2024

India’s lower-income groups face significant financial challenges when it comes to cancer treatment. High medical costs, lack of insurance coverage, and limited access to quality healthcare services exacerbate the situation. Many families are seen to opt between basic necessities and treatment, leading to increased mortality rates and a higher burden of disease.

Clinical Trials 152

Clinical Trials Clinical Trials Clinical Research Trials 152

Bio Pharma Dive

JULY 23, 2024

Peter Lebowitz, who for years led J&J’s oncology R&D, is the CEO of the startup, called Third Arc Bio and launched by Omega Funds in 2022.

Drugs 207

Drugs 207

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Pharmaceutical Technology

JULY 22, 2024

The EMA has accepted for review GSK’s MAA for Blenrep for relapsed or refractory multiple myeloma (r/r MM).

233

233

pharmaphorum

JULY 23, 2024

Former Welsh rugby union captain Alum Wyn Jones is the face of a new awareness campaign launching in the UK today to draw attention to atrial fibrillation (AF), an irregular and potentially life-threatening heart rhythm abnormality.

115

115

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 23, 2024

Over the last two years, Sahyadri Hospitals in Pune has observed a troubling trend of increase in cases of pulmonary embolism (PE) associated with long-haul international travel. This insight comes after the successful treatment of 17 PE cases through mechanical thrombectomy at the hospital—a procedure chosen for its efficacy when traditional clot-dissolving medications are unsuitable.

Doctors 146

Doctors Doctor Clinical Trials Clinical Trials 146

Bio Pharma Dive

JULY 25, 2024

CEO Thomas Schinecker claimed the company has “many opportunities” to stand out in the competitive field, and can get to market “much faster” than investors expect.

Drugs 171

Drugs Marketing 171

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials